ITAT allows weighted Income Tax Deduction u/s 32(2AB) wrt expenses incurred on clinical trials

The Income Tax Appellate Tribunal (ITAT) has permitted a weighted deduction under Section 35(2AB) of the Income Tax Act for expenses related to clinical trials. This decision supports the taxpayer’s claim for increased deductions on research and development costs. The tribunal emphasized that the statutory provisions allow such deductions, and it rejected the revenue authorities' argument against them. The ruling reinforces that companies investing in clinical research are eligible for enhanced tax benefits, promoting continued investment in healthcare innovations.